💊 Endoglycosidase NDCs, Ingredients & Package Codes
NDC package records in the Endoglycosidase class — ingredients, strengths, dosage forms, labelers, package codes and pricing data where available, with links to each individual NDC page. (Established Pharmacologic Class is the FDA’s grouping of “what kind of drug this is.”)
30
Package NDCs
49
Products
49
Active listings
14
Ingredients
10
Labelers
24
Strengths
4
Dosage forms
1
With NADAC pricing
Inside this class
Top ingredients by product count
Top labelers
Dosage forms
Browse records
💉
AMPHADASE hyaluronidase 150 [USP'U]/mL INJECTION
Rx only
Brand
On market
Non-controlled
—
💉
Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION
Rx only
Brand
On market
Non-controlled
—
💉
Darzalex Faspro daratumumab and hyaluronidase-fihj (human recombinant) 1800 mg/15mL; 30000 U/15mL INJECTION
Rx only
Brand
On market
Non-controlled
—
💧
—
💉
Herceptin Hylecta Trastuzumab and hyaluronidase-oysk 600 mg/5mL; 10000 U/5mL INJECTION, SOLUTION
Rx only
Brand
Discontinued
Non-controlled
—
💉
Herceptin Hylecta Trastuzumab and hyaluronidase-oysk 600 mg/5mL; 10000 U/5mL INJECTION, SOLUTION
Rx only
Brand
Discontinued
Non-controlled
—
💉
HYALURONIDASE 150 [USP'U]/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
HYLENEX Recombinant Hyaluronidase 150 [USP'U]/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
$53.688/unit · NADAC
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
KEYTRUDA QLEX pembrolizumab and berahyaluronidase alfa-pmph 165 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Ocrevus Zunovo ocrelizumab and hyaluronidase 920 mg/23mL; 23000 U/23mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
OPDIVO QVANTIG nivolumab and hyaluronidase-nvhy 120 mg/mL; 2000 U/mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
🧴
—
🧴
—
💉
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 1200 mg/15mL; 600 mg/15mL; 30000 U/15mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 600 mg/10mL; 600 mg/10mL; 20000 U/10mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
💉
Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 600 mg/10mL; 600 mg/10mL; 20000 U/10mL INJECTION, SOLUTION
Rx only
Brand
On market
Non-controlled
—
Where does this data come from?
Class membership is the FDA Established Pharmacologic Class (EPC) from the openFDA NDC Directory; ingredient, labeler, strength and form counts are aggregated from the same source, with NADAC pricing from CMS.
Browse other drug classes
Nonsteroidal Anti-inflammatory Drug 4,207
Corticosteroid 3,171
Central Nervous System Stimulant 2,773
Histamine-1 Receptor Antagonist 2,696
Antiarrhythmic 2,454
Amide Local Anesthetic 2,342
Sigma-1 Agonist 2,309
beta-Adrenergic Blocker 1,930
Uncompetitive N-methyl-D-aspartate Receptor Antagonist 1,818
Atypical Antipsychotic 1,744
Opioid Agonist 1,687
Expectorant 1,654
Calculi Dissolution Agent 1,593
HMG-CoA Reductase Inhibitor 1,513
Angiotensin 2 Receptor Blocker 1,490
Copper Absorption Inhibitor 1,453
Blood Coagulation Factor 1,340
Serotonin Reuptake Inhibitor 1,324
Non-Standardized Food Allergenic Extract 1,171
Non-Standardized Pollen Allergenic Extract 1,160
Proton Pump Inhibitor 1,144
Osmotic Laxative 1,133
Anti-epileptic Agent 1,125
Calcium Channel Blocker 1,119
alpha-1 Adrenergic Agonist 1,092
Penicillin-class Antibacterial 1,069
Azole Antifungal 1,054
Angiotensin Converting Enzyme Inhibitor 1,039
Non-Standardized Plant Allergenic Extract 1,008
Benzodiazepine 996
Cholinergic Nicotinic Agonist 948
alpha-Adrenergic Agonist 942
Phosphate Binder 920
Thiazide Diuretic 909
Antihistamine 886
Biguanide 854